Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT (MRK:NYSE)Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT (MRK:NYSE)
Merck & Co. (MRK) is close to an approximately $6 billion all-cash deal to buy US biotech firm Terns Pharmaceuticals{...}